[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PE20011180A1 - Vacuna contra la salmonella materiales y metodos - Google Patents

Vacuna contra la salmonella materiales y metodos

Info

Publication number
PE20011180A1
PE20011180A1 PE2001000253A PE2001000253A PE20011180A1 PE 20011180 A1 PE20011180 A1 PE 20011180A1 PE 2001000253 A PE2001000253 A PE 2001000253A PE 2001000253 A PE2001000253 A PE 2001000253A PE 20011180 A1 PE20011180 A1 PE 20011180A1
Authority
PE
Peru
Prior art keywords
nucleotides
salmonella
sequences
ssat
region
Prior art date
Application number
PE2001000253A
Other languages
English (en)
Inventor
David E Lowery
Michael J Kennedy
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PE20011180A1 publication Critical patent/PE20011180A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255Salmonella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UNA VACUNA QUE CONTIENE UNA CANTIDAD INMUNOLOGICAMENTE PROTECTORA DE SALMONELLA MUTANTE INCAPAZ DE REVERTIR, EN LA QUE SE HA INACTIVADO DOS O MAS GENES DENTRO DE LA REGION ISLA DE PATOGENICIDAD 2 EN SALMONELLA (IP2S); POR SUPRESION DE UNA PORCION DE LA REGION CODIFICANTE DEL GEN DEL APARATO DEL SISTEMA DE SECRECION SSA SELECCIONANDOSE DE SSAT QUE PRESENTA 779 NUCLEOTIDOS, SSAJ DE 749 NUCLEOTIDOS, SSAC DE 1052 NUCLEOTIDOS, SSAM DE 368 NUCLEOTIDOS O EL TRAMO COMPLETO DE LAS SECUENCIAS DE NUCLEOTIDOS QUE SE HIBRIDIZA CON EL COMPLEMENTO NO CODIFICANTE DE LA SECUENCIA DE DICHAS SECUENCIAS DE NUCLEOTIDOS, EN CONDICIONES RIGUROSAS, O UN TRAMO COMPLETO DE LAS SECUENCIAS DE NUCLEOTIDOS DE SALMONELLA QUE POSEE 95% DE IDENTIDAD DE LAS SECUENCIAS DE SSAT, SSAJ, SSAC, SSAM; O MEDIANTE MUTACION POR INSERCION. TAMBIEN SE REFIERE A UNA COMPOSICION QUE COMPRENDE ADEMAS UNA SEGUNDA SALMONELLA MUTANTE ATENUADA EN LA QUE SE HAN INACTIVADO UNO O MAS GENES DENTRO DE LA REGION IP2S; QUE SE CARACTERIZAN POR PERTENECER A SEROTIPOS DIFERENTES COMO SALMONELLA ENTERICA, S. DUBLIN, S.TYPHIMURIUM SUBESPECIE ENTERICA O CUALQUIERA DE LOS SIGUIENTES SEROGRUPOS A, B, C1, C2, D1, E1
PE2001000253A 2000-03-17 2001-03-16 Vacuna contra la salmonella materiales y metodos PE20011180A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19017800P 2000-03-17 2000-03-17

Publications (1)

Publication Number Publication Date
PE20011180A1 true PE20011180A1 (es) 2001-11-15

Family

ID=22700305

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000253A PE20011180A1 (es) 2000-03-17 2001-03-16 Vacuna contra la salmonella materiales y metodos

Country Status (17)

Country Link
US (2) US6923957B2 (es)
EP (1) EP1267899B1 (es)
JP (1) JP2003527433A (es)
AR (1) AR027680A1 (es)
AT (1) ATE300949T1 (es)
AU (2) AU5695701A (es)
BR (1) BR0109322A (es)
CA (1) CA2402252A1 (es)
DE (1) DE60112413T2 (es)
DK (1) DK1267899T3 (es)
ES (1) ES2244617T3 (es)
MX (1) MXPA02008748A (es)
NZ (1) NZ521425A (es)
PE (1) PE20011180A1 (es)
PT (1) PT1267899E (es)
WO (1) WO2001070247A2 (es)
ZA (1) ZA200207002B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE300949T1 (de) * 2000-03-17 2005-08-15 Pharmacia & Upjohn Co Llc Ssa inaktivierte salmonella impfstoffe
AU2004204751A1 (en) * 2003-01-09 2004-07-29 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
CN1297315C (zh) * 2004-11-25 2007-01-31 上海交通大学 抗仔猪细菌性疫病复合卵黄抗体制剂的制备方法
EP1882036B1 (en) * 2005-05-17 2012-02-15 Ozgene Pty Ltd Sequential cloning system
US20070191736A1 (en) * 2005-10-04 2007-08-16 Don Alden Method for loading penetrating members in a collection device
CN101522210B (zh) 2006-09-18 2017-03-22 阿肯色大学评议会 增强免疫应答的组合物和方法
UA100370C2 (uk) * 2006-12-11 2012-12-25 Мериал Лимитед Спосіб вакцинації птахів проти salmonella
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
WO2009059018A1 (en) * 2007-10-30 2009-05-07 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to flagellated bacterium
HUE047164T2 (hu) 2007-11-01 2020-04-28 Univ Arkansas Kompozíciók és eljárások eimeria elleni immunválasz fokozására
EP2217716A4 (en) 2007-11-09 2011-02-09 Salk Inst For Biological Studi USE OF TAM RECEPTOR INHIBITORS AS ANTIMICROBIAL AGENTS
NO2525817T3 (es) 2010-01-21 2018-01-06
CN102971008B (zh) 2010-06-09 2015-11-25 阿肯色大学评议会 降低弯曲菌属感染的疫苗和方法
WO2012123269A1 (en) 2011-03-11 2012-09-20 Proyecto De Biomedicina Cima, S.L. Immunogenic compositions and methods for their use
US8481052B2 (en) 2011-05-17 2013-07-09 Cj Cheiljedang Corporation Avirulent Salmonella gallinarum variants and pharmaceutical composition using the same
US9950053B2 (en) 2012-10-22 2018-04-24 The Board Of Regents For Oklahoma State University Use of the Salmonella SPP type III secretion proteins as a protective vaccination
US10548962B2 (en) 2012-10-22 2020-02-04 The Board Of Regents For Oklahoma State University Use of the salmonella SPP type III secretion proteins as a protective vaccination
US20150238590A1 (en) * 2012-10-22 2015-08-27 The Board Of Regents For Oklahoma State University Use of the salmonella spp type iii secretion proteins as a protective vaccination
KR102228324B1 (ko) 2013-02-14 2021-03-15 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 에이메리아에 대한 면역 반응을 증진시키거나, 에이메리아 감염을 제한하는 조성물 및 방법
KR102239207B1 (ko) 2013-03-15 2021-04-09 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 장내 병원균에 대한 면역 반응을 증진시키는 조성물 및 방법
WO2016077453A1 (en) * 2014-11-11 2016-05-19 Ohio State Innovation Foundation Probiotic bacteria for the prevention and treatment of salmonella
US20170072042A1 (en) * 2015-09-16 2017-03-16 Boehringer Ingelheim Vetmedica, Inc. Salmonella choleraesuis-salmonella typhimurium vaccines
WO2017192671A1 (en) 2016-05-03 2017-11-09 The Board Of Trustees Of The University Of Arkansas Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US4877612A (en) 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
EP0231039B1 (en) 1986-01-14 1992-01-08 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Process for preparing immunological complexes and pharmaceutical composition containing these complexes
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
NZ296581A (en) 1994-12-09 2000-02-28 Imp College Innovations Ltd A method of identifying genes identified in a microorganisms ability to adapt to changes in its environment
JP2002524077A (ja) * 1998-09-04 2002-08-06 クリートゲン アクチエンゲゼルシャフト 抗原キャリヤーとしての弱毒化サルモネラspi2突然変異体
NZ519477A (en) * 1999-12-23 2004-04-30 Microscience Ltd Attenuated microorganisms for the treatment of infection
ATE300949T1 (de) * 2000-03-17 2005-08-15 Pharmacia & Upjohn Co Llc Ssa inaktivierte salmonella impfstoffe

Also Published As

Publication number Publication date
BR0109322A (pt) 2002-12-10
ATE300949T1 (de) 2005-08-15
DK1267899T3 (da) 2005-12-12
US6923957B2 (en) 2005-08-02
US20040009191A1 (en) 2004-01-15
EP1267899A2 (en) 2003-01-02
ZA200207002B (en) 2004-03-31
EP1267899B1 (en) 2005-08-03
CA2402252A1 (en) 2001-09-27
PT1267899E (pt) 2005-11-30
WO2001070247A3 (en) 2002-04-18
JP2003527433A (ja) 2003-09-16
AR027680A1 (es) 2003-04-09
WO2001070247A2 (en) 2001-09-27
MXPA02008748A (es) 2003-02-24
AU5695701A (en) 2001-10-03
DE60112413T2 (de) 2006-06-01
US20050260223A1 (en) 2005-11-24
NZ521425A (en) 2004-05-28
ES2244617T3 (es) 2005-12-16
DE60112413D1 (de) 2005-09-08
AU2001256957B2 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
PE20011180A1 (es) Vacuna contra la salmonella materiales y metodos
ES2156110T3 (es) Analogos de sub-unidades de toxina del colera derivados de adn recombinante.
Mulder et al. Identification of additional virulence determinants on the pYV plasmid of Yersinia enterocolitica W227
ES2181306T3 (es) Vacunas recombinantes que comprenden bacterias atenuadas inmunogenicas que tienen fenotipo rpos positivo.
PT672116E (pt) Mutantes por supressao como vacinas contra a colera
CL2008003202A1 (es) Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
UA98812C2 (ru) Авирулентная активированная живая вакцина mycoplasma hyopneumoniae
Preethee et al. Molecular identification of an Enterococcus faecalis endocarditis antigen efaA in root canals of therapy-resistant endodontic infections
AR044696A1 (es) Composicion de vacunas
Iskra-Caruana et al. The common evolutionary history of badnaviruses and banana
BR0010418A (pt) Microorganismos atenuados para o tratamento de infecção
Damé-Teixeira et al. Genotypic diversity and virulence traits of Streptococcus mutans isolated from carious dentin after partial caries removal and sealing
Pereira et al. Molecular characterization of feline calicivirus variants from multicat household and public animal shelter in Rio de Janeiro, Brazil
Raviv et al. Strain differentiating real-time PCR for Mycoplasma gallisepticum live vaccine evaluation studies
DK1154791T3 (da) Neisseria-vaccinesammensætninger og fremgangsmåder
CL2023001826A1 (es) Eliminación genómica en la vacuna contra la peste porcina africana que permite un crecimiento eficaz en estirpes celulares estables
Bertone et al. Genetic-relatedness of peri-implants and buccal Candida albicans isolates determined by RAPD-PCR
TR200002974T2 (tr) Bruselloza karşı canlı aşı
Bedford et al. Further characterization of Shigella sonnei live vaccine candidates WRSs2 and WRSs3-plasmid composition, invasion assays and Sereny reactions
HUP0303878A2 (hu) Himlő elleni vakcina
ES2054230T3 (es) Un proceso para la preparacion de un enterovirus o rinovirus atenuado.
Sánchez-Jiménez et al. Distribution of pathogenicity islands among Colombian isolates of Salmonella
ES2120989T3 (es) Vector virico recombinante de tipo varicela-zoster.
HUP9702355A2 (hu) Avirulens Mycoplasma synoviae, és az ezt tartalmazó vakcina
Leal et al. RAPD-PCR typing of Yersinia enterocolitica (Enterobacteriaceae) O: 3 serotype strains isolated from pigs and humans

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed